Its not, its something else. And that something else is none of anyones business, Goldberg affirmed
So thats just the joy of medicine, saying, well, lets look that up together
(In the past, Siegel received research funds from Vivus, which makes Qsymia, a weight-loss medication that is not a GLP-1 agonist.) GLP-1 agonist medications cause the pancreas to release insulin, which helps control blood sugar, and they slow your gastrointestinal tract down, making you feel full longer and reducing hunger, he explains
And we don't want to have adverse effects
This ensures consistent quality, accurate dose delivery, and safety with every injection